FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status

PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall

Read more

Serious, ‘Unexpected’ Adverse Events From Nasal Esketamine

Patients who receive esketamine for treatment-resistant depression (TRD) are at increased risk for serious and unexpected adverse events (AEs), new

Read more

US Government Directs Johnson & Johnson to Run Vaccine Plant

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Federal health officials on Saturday put

Read more